Candriam S.C.A. Purchases 7,247 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Candriam S.C.A. grew its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 7.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 109,734 shares of the pharmacy operator’s stock after buying an additional 7,247 shares during the quarter. Candriam S.C.A.’s holdings in Walgreens Boots Alliance were worth $1,024,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently modified their holdings of the company. State Street Corp increased its stake in shares of Walgreens Boots Alliance by 18.0% in the 3rd quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator’s stock worth $385,258,000 after purchasing an additional 6,569,223 shares in the last quarter. Charles Schwab Investment Management Inc. increased its stake in shares of Walgreens Boots Alliance by 19.9% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 13,155,138 shares of the pharmacy operator’s stock worth $122,737,000 after purchasing an additional 2,185,950 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in shares of Walgreens Boots Alliance by 12.1% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 7,594,475 shares of the pharmacy operator’s stock worth $68,046,000 after purchasing an additional 817,762 shares in the last quarter. Thompson Siegel & Walmsley LLC increased its stake in shares of Walgreens Boots Alliance by 15.5% in the 3rd quarter. Thompson Siegel & Walmsley LLC now owns 6,955,880 shares of the pharmacy operator’s stock worth $62,325,000 after purchasing an additional 934,754 shares in the last quarter. Finally, Bank of New York Mellon Corp increased its stake in shares of Walgreens Boots Alliance by 9.6% in the 4th quarter. Bank of New York Mellon Corp now owns 5,432,383 shares of the pharmacy operator’s stock worth $50,684,000 after purchasing an additional 478,061 shares in the last quarter. 58.59% of the stock is owned by institutional investors.

Walgreens Boots Alliance Trading Down 1.0 %

Shares of Walgreens Boots Alliance stock opened at $11.28 on Tuesday. The firm has a market cap of $9.75 billion, a price-to-earnings ratio of -1.10, a PEG ratio of 1.31 and a beta of 0.62. The business has a 50-day moving average price of $10.68 and a 200-day moving average price of $9.72. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $22.05.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. The firm had revenue of $39.50 billion during the quarter, compared to analyst estimates of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business’s quarterly revenue was up 7.6% compared to the same quarter last year. During the same quarter last year, the business posted $0.66 earnings per share. Equities research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Wall Street Analyst Weigh In

WBA has been the subject of several analyst reports. Royal Bank of Canada upped their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a research note on Wednesday, January 15th. Deutsche Bank Aktiengesellschaft lowered Walgreens Boots Alliance from a “hold” rating to a “sell” rating and reduced their price objective for the stock from $11.00 to $9.00 in a research note on Friday, February 28th. Evercore ISI increased their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research note on Monday, January 13th. Bank of America increased their price target on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a research note on Monday, January 13th. Finally, Truist Financial cut their price target on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research note on Friday, January 31st. Four analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $11.54.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.